<p>So far, <strong>DuPont</strong> ( DD ) had a decent performance in fiscal 2017. As of February 15, 2017, DuPont rose 6.2%, but it underperformed its peers <strong>Dow Chemica</strong>l ( DOW ), <strong>Eastman Chemica</strong>l ( EMN ), and <strong>LyondellBasell</strong> ( LYB ). They have returned 6.8%, 7.5%, and 8.5%, respectively. However, DuPont managed to outperform the broader market representative the SPDR S P 500 ( SPY ). SPY returned 5.1% during the same period. It tracks the S P 500 Index (SPX). Gains in DuPont&rsquo;s stock price are influenced by good 4Q16 earnings. The gains are supported by the bullish market in the US. The merger between <strong>Dow Chemical</strong> and <strong>DuPont</strong> is expected to be completed in 2Q17. The deal is still being reviewed by EU regulators. At the beginning of February,<strong> Dow Chemica</strong>l sold some of its business to accommodate regulatory approval for the proposed merger. With <strong>DuPont</strong> stock continuing to rise, <strong>DuPont</strong> is trading 8.1% above its 100-day moving average of $72.10. The movement indicates the stock&rsquo;s upward trend. <strong>DuPont&rsquo;s</strong> 52-week low is $57.76, while its 52-week high is $78.09. Analysts&rsquo; consensus indicates a 12-month price target of 82.45. It implies a potential return of 5.8% from the closing price of $77.94 on February 15, 2016. The stock&rsquo;s 14-day RSI (relative strength index) of 66 indicates that it isn&rsquo;t oversold or overbought. An RSI of 70 means that a stock has moved temporarily into an overbought situation, while an RSI of below 30 indicates that a stock has moved temporarily into an oversold position. Quote data by <strong>Xignite</strong></p>
